Skip to content

Author

M. O. Oyovwi

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

Comparative predictive performance of insulin resistance surrogates (TyG and TyG-BMI) and lipid indices for cardiometabolic risk in prehypertensive adults

Prehypertension is the initial stage of the risk pathway of CVD, which commonly associates with hidden metabolic derangements such as insulin resistance and dyslipidemia. In the clinical setting, convenient, inexpensive predictors for early screening are required, particularly in underprivileged countries. This study e...

A. Atere, M. Moronkeji, M. O. Oyovwi et al. · 0 citations
Open access Jul 2026

Clinical Significance of Lipoprotein and Ceruloplasmin Variations in Type 2 Diabetes Mellitus: A Cross-Sectional Study in Owo, Nigeria

Ceruloplasmin was raised in T2DM, dyslipidemia, and lowered antioxidant capability were early markers that prompt intervention for oxidative stress and biochemical derangements in patients with T2DM.

A. Atere, Oluomachi Precious Nwimo, M. O. Oyovwi et al. · 0 citations
Open access Jul 2026

Prenatal Paroxetine Exposure Alters Oxidative, Inflammatory, Neurobehavioural, and Cholinergic Markers in the Hippocampus of Male and Female Mice Offspring in a Depression Model

Key findings showed that paroxetine causes reduced brain weight especially in female than male with an increase correct alternation activities in infancy and adulthood than in adolescent with altering effects in neuronal weight and enzymes, oxidation and concentration in release of cytokines in the hippocampal brain re...

I. Efejene, B. Ben-Azu, A. Eduviere et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.